In total, 16 studies [16,17,25,26,27,28,29,30,31,32,33,34,35,36,37,38] have already reported a comparison between the Idylla method and other molecular reference methods for the assessment of the BRAF V600E mutation in melanoma patients at the time of the publication (Table 5). This evidence concerns the gene BRAF and melanoma.